Our study also showed that the maximum increase in the number of CD3+ T cells expressing CTLA-4 was achieved in patients with CLL without molecular markers for virus presence after 72 h of stimulation with EBV peptides. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.